2021
DOI: 10.1093/narcan/zcab006
|View full text |Cite
|
Sign up to set email alerts
|

Ribosomal RNA 2′ O-methylation as a novel layer of inter-tumour heterogeneity in breast cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
11
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 6 publications
(14 citation statements)
references
References 1 publication
(1 reference statement)
3
11
0
Order By: Relevance
“…Recently, a RiboMethSeq analysis was applied to large clinical cohorts of breast cancer tissues and diffuse large B-cell lymphoma samples [ 26 , 27 ]. Since identical analytical technique (albeit in different flavours) was applied in both studies, the results can be compared almost directly.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Recently, a RiboMethSeq analysis was applied to large clinical cohorts of breast cancer tissues and diffuse large B-cell lymphoma samples [ 26 , 27 ]. Since identical analytical technique (albeit in different flavours) was applied in both studies, the results can be compared almost directly.…”
Section: Discussionmentioning
confidence: 99%
“…With the development of different versions of RiboMethSeq [ 8 , 24 , 25 ], see [ 23 ] for a review, a comprehensive profiling of variably modified rRNA Nm residues become possible, but was systematically performed only for some model human cell lines (e.g. HeLa/HCT116 cells) [ 5 ] as well as in two different cancer models: breast cancer tissues and B-cell lymphoma [ 26 , 27 ]. The latter study revealed pronounced hypomethylation of some rRNA Nm sites (namely 18S-Um354, 18S-Cm1440 and 28S-Gm4593).…”
Section: Introductionmentioning
confidence: 99%
“…A first line of evidence supporting the hypothesis that tRNA and rRNA modifications are not static comes from the observation that these chemical decorations vary in human diseases including cancer [ 14–22 ]. For example, two recent studies revealed a global reduction of rRNA 2ʹ- O -methylation at some rRNA sites (named variable sites) in two types of human tumours compared to their corresponding level in normal tissue [ 21 , 22 ]. These new cancer-related hypomethylated patterns were found to be tumour-specific and associated with tumour aggressiveness [ 21 , 22 ].…”
Section: Introductionmentioning
confidence: 99%
“…For example, two recent studies revealed a global reduction of rRNA 2ʹ- O -methylation at some rRNA sites (named variable sites) in two types of human tumours compared to their corresponding level in normal tissue [ 21 , 22 ]. These new cancer-related hypomethylated patterns were found to be tumour-specific and associated with tumour aggressiveness [ 21 , 22 ]. In contrast, the global level of tRNA modifications is generally higher in cancer cells compared to their corresponding level in normal tissue [ 23 ].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation